Search Results - "Slezak, Anna J."
-
1
Topically-applied collagen-binding serum albumin-fused interleukin-4 modulates wound microenvironment in non-healing wounds
Published in npj Regenerative medicine (11-09-2023)“…Non-healing wounds have a negative impact on quality of life and account for many cases of amputation and even early death among patients. Diabetic patients…”
Get full text
Journal Article -
2
-
3
Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker
Published in Nature biomedical engineering (01-07-2022)“…Immune-checkpoint inhibitors have shown modest efficacy against immunologically ‘cold’ tumours. Interleukin-12 (IL-12)—a cytokine that promotes the recruitment…”
Get full text
Journal Article -
4
Synthetically mannosylated antigens induce antigen-specific humoral tolerance and reduce anti-drug antibody responses to immunogenic biologics
Published in Cell reports. Medicine (16-01-2024)“…Immunogenic biologics trigger an anti-drug antibody (ADA) response in patients that reduces efficacy and increases adverse reactions. Our laboratory has shown…”
Get full text
Journal Article -
5
Mannose-Decorated Co-Polymer Facilitates Controlled Release of Butyrate to Accelerate Chronic Wound Healing
Published in Advanced healthcare materials (01-10-2023)“…Butyrate is a key bacterial metabolite that plays an important and complex role in modulation of immunity and maintenance of epithelial barriers. Its…”
Get full text
Journal Article -
6
Synthetically glycosylated antigens for the antigen-specific suppression of established immune responses
Published in Nature biomedical engineering (01-09-2023)“…Inducing antigen-specific tolerance during an established immune response typically requires non-specific immunosuppressive signalling molecules. Hence,…”
Get full text
Journal Article -
7
A serine-conjugated butyrate prodrug with high oral bioavailability suppresses autoimmune arthritis and neuroinflammation in mice
Published in Nature biomedical engineering (01-05-2024)“…Butyrate—a metabolite produced by commensal bacteria—has been extensively studied for its immunomodulatory effects on immune cells, including regulatory T…”
Get full text
Journal Article -
8
Cysteine-binding adjuvant enhances survival and promotes immune function in a murine model of acute myeloid leukemia
Published in Blood advances (09-04-2024)“…•We present a novel immunotherapy platform for hematological cancers that exploits fundamental metabolic dysregulation of cancer cells.•Our multivalent,…”
Get full text
Journal Article -
9
Glycosylation-modified antigens as a tolerance-inducing vaccine platform prevent anaphylaxis in a pre-clinical model of food allergy
Published in Cell reports. Medicine (16-01-2024)“…The only FDA-approved oral immunotherapy for a food allergy provides protection against accidental exposure to peanuts. However, this therapy often causes…”
Get full text
Journal Article -
10
Tumor Cell-Surface Binding of Immune Stimulating Polymeric Glyco-Adjuvant via Cysteine-Reactive Pyridyl Disulfide Promotes Antitumor Immunity
Published in ACS central science (26-10-2022)“…Immune stimulating agents like Toll-like receptor 7 (TLR7) agonists induce potent antitumor immunity but are limited in their therapeutic window due to…”
Get full text
Journal Article -
11
Engineered IL-7 synergizes with IL-12 immunotherapy to prevent T cell exhaustion and promote memory without exacerbating toxicity
Published in Science advances (01-12-2023)“…Cancer immunotherapy is moving toward combination regimens with agents of complementary mechanisms of action to achieve more frequent and robust efficacy…”
Get full text
Journal Article -
12
Delivery of butyrate to the lower gut by polymeric micelles prolongs survival of distal skin allografts
Published in American journal of transplantation (01-11-2024)Get full text
Journal Article